FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,939 Cr | ₹3,643 Cr | ₹3,317 Cr | ₹3,180 Cr | ₹3,038 Cr |
What is the latest Total Liabilities ratio of FDC ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹3,939 Cr |
| Mar2025 | ₹3,643 Cr |
| Mar2024 | ₹3,317 Cr |
| Mar2023 | ₹3,180 Cr |
| Mar2022 | ₹3,038 Cr |
How is Total Liabilities of FDC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,939 Cr | 8.11 | |
| Mar2025 | ₹3,643 Cr | 9.85 | |
| Mar2024 | ₹3,317 Cr | 4.31 | |
| Mar2023 | ₹3,180 Cr | 4.66 | |
| Mar2022 | ₹3,038 Cr | - | |
Compare Total Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,148.1 Cr | -0.3% | 11% | -8.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -0.3% |
11% |
-8.4% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses